Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Acute kidney injury in patients with severe COVID-19

Gustavo A. Casas-Aparicio, Isabel León-Rodríguez, Mauricio González-Navarro, Claudia Alvarado-de la Barrera, Santiago Ávila-Ríos, Amy Peralta-Prado, Yara Luna-Villalobos, Alejandro Velasco-Morales, Natalia Calderón-Dávila
doi: https://doi.org/10.1101/2020.08.28.20167379
Gustavo A. Casas-Aparicio
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gustavo.casas@cieni.org.mx
Isabel León-Rodríguez
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricio González-Navarro
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Alvarado-de la Barrera
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santiago Ávila-Ríos
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Peralta-Prado
2Departamento de Epidemiología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yara Luna-Villalobos
1Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Velasco-Morales
3Resident doctor at the Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Calderón-Dávila
3Resident doctor at the Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction Some patients with COVID-19 pneumonia present systemic disease involving multiple systems. There is limited information about the clinical characteristics and events leading to acute kidney injury (AKI). We described the factors associated with the development of AKI and explored the relation of AKI and mortality in Mexican population with severe COVID-19.

Methods We retrospectively reviewed the medical records of individuals with severe pneumonia caused by SARS-CoV-2 hospitalized at the largest third-level reference institution for COVID-19 care in Mexico between March and April 2020. Demographic information, comorbidities, clinical and laboratory data, dates of mechanical ventilation and hospitalization, mechanical-ventilator settings and use of vasoactive drugs were recorded.

Results Of 99 patients studied, 58 developed AKI (58.6%). The group with AKI had higher body mass index (p=0.0003) and frequency of obesity (p=0.001); a higher requirement of invasive mechanical ventilation (p=0.008) and vasoactive drugs (p=0.004); greater levels of serum creatinine (p<0.001) and D-dimer on admission (p<0.001); and lower lymphocyte counts (p=0.001) than the non-AKI group. The multivariate analysis indicated that risk factors for AKI were obesity (adjusted hazard ratio (HR)=2.71, 95% confidence interval (CI)=1.33-5.51, p=0.005); higher serum creatinine (HR=1.44, CI=1.02- 2.02, p=0.035) and D-dimer levels on admission (HR=1.14, CI=1.06-1.23, p<0.001). Inhospital mortality was higher in the AKI group than in the non-AKI group (65.5% vs. 14.6%; p=0.001).

Conclusions AKI was common in our cohort of patients with severe COVID-19 and it was associated with mortality. The risk factors for AKI were obesity, elevated creatinine levels and higher D-dimer levels on admission.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any type of financial support and was carried out with staff from the National Institute of Respiratory Diseases

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The work was approved by the ethics committee of the National Institute of Respiratory Diseases and, given the retrospective nature of the study, informed consent was not necessary.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We have the approval of the approved ethics committee and the database of our protocol.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Acute kidney injury in patients with severe COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Acute kidney injury in patients with severe COVID-19
Gustavo A. Casas-Aparicio, Isabel León-Rodríguez, Mauricio González-Navarro, Claudia Alvarado-de la Barrera, Santiago Ávila-Ríos, Amy Peralta-Prado, Yara Luna-Villalobos, Alejandro Velasco-Morales, Natalia Calderón-Dávila
medRxiv 2020.08.28.20167379; doi: https://doi.org/10.1101/2020.08.28.20167379
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Acute kidney injury in patients with severe COVID-19
Gustavo A. Casas-Aparicio, Isabel León-Rodríguez, Mauricio González-Navarro, Claudia Alvarado-de la Barrera, Santiago Ávila-Ríos, Amy Peralta-Prado, Yara Luna-Villalobos, Alejandro Velasco-Morales, Natalia Calderón-Dávila
medRxiv 2020.08.28.20167379; doi: https://doi.org/10.1101/2020.08.28.20167379

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nephrology
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (416)
  • Anesthesia (92)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
  • Epidemiology (8589)
  • Forensic Medicine (4)
  • Gastroenterology (390)
  • Genetic and Genomic Medicine (1772)
  • Geriatric Medicine (169)
  • Health Economics (375)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (197)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10344)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (933)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (255)
  • Pediatrics (539)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1785)
  • Public and Global Health (3871)
  • Radiology and Imaging (627)
  • Rehabilitation Medicine and Physical Therapy (322)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (170)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)